Acute monocytic leukemia
A subtype of acute myeloid leukemia
| Classification |
|
|---|---|
| External resources |
|
Acute monocytic leukemia (AML-M5) is a subtype of acute myeloid leukemia (AML), a cancer of the blood and bone marrow characterized by an overproduction of immature white blood cells known as monocytes. This condition is classified under the French-American-British (FAB) classification system as M5, which is further divided into M5a (poorly differentiated) and M5b (well differentiated).
Pathophysiology[edit | edit source]
Acute monocytic leukemia is characterized by the proliferation of monoblasts and promonocytes in the bone marrow and peripheral blood. These cells are part of the monocyte lineage, which normally develop into macrophages and dendritic cells that play a role in the immune system. In AML-M5, these cells fail to mature properly and accumulate, disrupting normal blood cell production.
Clinical Presentation[edit | edit source]
Patients with acute monocytic leukemia may present with symptoms related to anemia, thrombocytopenia, and neutropenia. Common symptoms include fatigue, pallor, easy bruising, bleeding, and increased susceptibility to infections. Additionally, due to the infiltration of leukemic cells, patients may experience gum hypertrophy, skin lesions, and central nervous system involvement.
Diagnosis[edit | edit source]
The diagnosis of acute monocytic leukemia is made through a combination of blood tests, bone marrow biopsy, and cytogenetic analysis. A complete blood count (CBC) often reveals leukocytosis with a high percentage of monoblasts. Bone marrow examination shows a predominance of monoblasts and promonocytes. Flow cytometry and immunophenotyping are used to confirm the monocytic lineage of the leukemic cells.
Treatment[edit | edit source]
The treatment of acute monocytic leukemia typically involves chemotherapy regimens similar to those used for other subtypes of AML. The standard induction therapy includes cytarabine and an anthracycline such as daunorubicin or idarubicin. Consolidation therapy may involve additional chemotherapy or hematopoietic stem cell transplantation for eligible patients.
Prognosis[edit | edit source]
The prognosis for patients with acute monocytic leukemia varies based on several factors, including age, overall health, and specific genetic abnormalities. Younger patients and those who achieve complete remission after initial treatment generally have a better prognosis. However, the overall survival rate remains lower compared to other AML subtypes.
Related pages[edit | edit source]
Gallery[edit | edit source]
Micrograph of acute monocytic leukemia
Acute monocytic leukemia
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
